Quest Laboratories (NSE:QUESTLAB) PS Ratio: 4.99 (As of Jun. 26, 2026) — 21% Above Median


NSE:QUESTLAB Quest Laboratories Ltd NSE:QUESTLAB
44 GF Score
Price ₹98.05
! 8 Warning Signs
View Full Analysis

What is Quest Laboratories PS Ratio?

Quest Laboratories NSE:QUESTLAB -1.56% 44 PS Ratio is 4.99 as of Jun. 26, 2026, which is 21% above its 10-year median of 4.14. GuruFocus rates NSE:QUESTLAB with a GF Score™ of 44/100. The stock has 8 warning signs investors should review. Among 953 Drug Manufacturers companies, Quest Laboratories ranks worse than 74.29% on this metric.

The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, Quest Laboratories's share price is ₹98.05. Quest Laboratories's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 was ₹19.64. Hence, Quest Laboratories's PS Ratio for today is 4.99.

Good Sign:

Quest Laboratories Ltd stock PS Ratio (=1.51) is close to 3-year low of 1.51.

The historical rank and industry rank for Quest Laboratories's PS Ratio or its related term are showing as below:

NSE:QUESTLAB' s PS Ratio Range Over the Past 10 Years
Min: 2.98   Med: 4.14   Max: 7.72
Current: 4.98

During the past 6 years, Quest Laboratories's highest PS Ratio was 7.72. The lowest was 2.98. And the median was 4.14.

NSE:QUESTLAB's PS Ratio is ranked worse than
74.29% of 953 companies
in the Drug Manufacturers industry
Industry Median: 2.2 vs NSE:QUESTLAB: 4.98

Quest Laboratories's Revenue per Sharefor the three months ended in Mar. 2026 was ₹19.64. Its Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 was ₹19.64.

Warning Sign:

Quest Laboratories Ltd revenue per share has been in decline over the past 3 years.

During the past 12 months, the average Revenue per Share Growth Rate of Quest Laboratories was 7.50% per year. During the past 3 years, the average Revenue per Share Growth Rate was -50.80% per year. During the past 5 years, the average Revenue per Share Growth Rate was 17.90% per year.

During the past 6 years, Quest Laboratories's highest 3-Year average Revenue per Share Growth Rate was 39.60% per year. The lowest was -50.80% per year. And the median was 20.50% per year.

Back to Basics: PS Ratio


Quest Laboratories  (NSE:QUESTLAB) PS Ratio Explanation

The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.

When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.

Similar to the PE Ratio or Price-to-Operating-Cash-Flow or Price-to-Free-Cash-Flow , the PS Ratio measures the valuation based on the earning power of the company. This is where it is different from the PB Ratio , which measures the valuation based on the company's balance sheet.


Be Aware

The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.


Quest Laboratories PS Ratio Related Terms


Quest Laboratories PS Ratio Historical Data

* Premium members only.

The historical data trend for Quest Laboratories's PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Quest Laboratories PS Ratio Chart

Quest Laboratories Annual Data
Trend Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
PS Ratio
Get a 7-Day Free Trial 0.00 0.00 0.00 1.61 1.53

Quest Laboratories Quarterly Data
Mar21 Mar22 Mar23 Sep23 Dec23 Mar24 Mar25 Mar26
PS Ratio Get a 7-Day Free Trial 0.00 0.00 0.00 1.61 1.53

NSE:QUESTLAB vs LLY, JNJ, ABBV: PS Ratio Comparison

For the Drug Manufacturers - General subindustry, Quest Laboratories's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Quest Laboratories PS Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Quest Laboratories's PS Ratio distribution charts can be found below:

* The bar in red indicates where Quest Laboratories's PS Ratio falls into.


NSE:QUESTLAB
44GF Score
Quest Laboratories Ltd NSE:QUESTLAB
PS Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Quest Laboratories PS Ratio Calculation

The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.

Quest Laboratories's PS Ratio for today is calculated as

PS Ratio=Share Price/Revenue per Share (TTM)
=98.05/19.643
=4.99

Quest Laboratories's Share Price of today is ₹98.05.
Quest Laboratories's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹19.64.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

PS Ratio=Market Cap/Revenue

The Revenue here is for the trailing 12 months.

Frequently Asked Questions Learn more about PS Ratio →
What does a PS Ratio of 4.99 mean?
Quest Laboratories (NSE:QUESTLAB) has a PS Ratio of 4.99 as of Jun. 26, 2026. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Quest Laboratories and its competitors. This is 21% above median its historical median of 4.14. Over the past decade, Quest Laboratories' PS Ratio has ranged from 2.98 to 7.72. According to the industry distribution chart, Quest Laboratories ranks #708 out of 953 companies in the Drug Manufacturers industry, placing it in the top 74.3%.
Is Quest Laboratories' PS Ratio too high?
Quest Laboratories' current PS Ratio of 4.99 is 21% above median its 10-year median of 4.14. Over the past 10 years, this metric has ranged from a low of 2.98 to a high of 7.72. The Drug Manufacturers industry median PS Ratio is 2.20. Quest Laboratories' value of 4.99 is 126.8% above this industry median. Based on the distribution chart, Quest Laboratories ranks #708 out of 953 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, Quest Laboratories has a GF Score™ of 44/100, reflecting its overall financial health beyond just this single metric.
How does Quest Laboratories' PS Ratio compare to LLY and JNJ?
According to the Drug Manufacturers industry distribution chart, Quest Laboratories ranks #708 out of 953 companies for PS Ratio. This places Quest Laboratories in the lower half of its industry. The industry median PS Ratio is 2.20. Quest Laboratories' value of 4.99 is 126.8% above this benchmark. Historically, Quest Laboratories' own PS Ratio has ranged from 2.98 to 7.72 over the past decade. While the company's 10-year median is 4.14 vs. the industry median of 2.20, Quest Laboratories has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PS Ratio for a Drug Manufacturers company?
The median PS Ratio among Drug Manufacturers companies is 2.20, based on 953 companies in the industry. Companies in the top quartile (top 25%) have a PS Ratio significantly above this median, while those in the bottom quartile fall well below. However, PS Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Quest Laboratories's current PS Ratio of 4.99 is 126.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PS Ratio mean?
A high PS Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Quest Laboratories and its competitors. For the Drug Manufacturers industry, the median PS Ratio is 2.20 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Quest Laboratories's current PS Ratio is 4.99, which is 21% above median its own 10-year median of 4.14. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Quest Laboratories stock overvalued right now?
Quest Laboratories (NSE:QUESTLAB) has a current PS Ratio of 4.99. The current PS Ratio is 4.99, which is 21% above median its 10-year median of 4.14 and 126.8% above the Drug Manufacturers industry median of 2.20. Quest Laboratories' overall GF Score™ is 44/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PS Ratio calculated?
PS Ratio is calculated from a company's financial statements. For Quest Laboratories (NSE:QUESTLAB), the current PS Ratio is 4.99 as of Jun. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Quest Laboratories Business Description

Address Sector III, Plot No. 45, Pithampur Industrial Area, Opposite Kissan Pipe Unit 4, District Dhar, Pithampur, Dhar, MP, IND, 454775
Quest Laboratories Ltd is engaged in the business of manufacturing pharmaceutical formulations across a broad spectrum, including antibiotics, antimalarials, antispasmodics, anti-inflammatories, antiemetics, respiratory medications, diabetes treatments, antidepressants, and more. It produces various products, comprising ethical drugs, generic drugs, and over-the-counter drugs, and is also available in various forms such as tablets, liquid orals, oral dry powders, oral powders (ORS), ointments, and external liquids, among others. The company operates in a single segment of Drugs and Chemicals.
44GF Score

Get the complete analysis for NSE:QUESTLAB

PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹98.05
Price